ADPTAdaptive Biotechnologies Corporation
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Choppy, but holding above its 200-day average. Oversold (RSI 30). Price is +33% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 12% since the previous count, up from 7.1% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ADPT is trading
Adaptive Biotechnologies Corporation is +48% over the past year while the S&P 500 is +16%: 32 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +33%
vs 200-day average · a clear uptrend
- RSI (14)
- 30
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 15%
Below its 52-week high
Details›
- Last close2026-10-23
- $25.51
- 1 monthS&P 500 −0.94%
- −14%
- 1 yearS&P 500 +16%
- +48%
- 5 yearsS&P 500 +86%
- −19%
- vs 50-day average$26.10
- −2.3%
- 52-week high
- $29.86
- 52-week low
- $12.41
- Annualised volatility
- 73%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $19M
| Year | Return |
|---|---|
| 2026 (year to date) | +57% |
| 2025 | +171% |
| 2024 | +22% |
| 2023 | −36% |
| 2022 | −73% |
| 2021 | −53% |
| 2020 | +98% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 3 of 7 | −0.67% |
| Feb | 7 | 3 of 7 | −3.4% |
| Mar | 7 | 1 of 7 | −11% |
| Apr | 7 | 3 of 7 | −8.4% |
| May | 7 | 4 of 7 | +10% |
| Jun | 7 | 6 of 7 | +15% |
| Jul | 8 | 4 of 8 | +0.53% |
| Aug | 8 | 5 of 8 | +7.8% |
| Sep | 8 | 4 of 8 | −3.7% |
| Oct | 8 | 2 of 8 | −4.1% |
| Nov | 7 | 5 of 7 | +4.9% |
| Dec | 7 | 5 of 7 | +3.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.
Diagnostics & Research
Ranks #12 of 21 by RyuScore